Public Image Ltd

The success of Pfizer, J&J and Moderna in developing Covid-19 jabs and scaling up production has buffed their reputations. The immediate financial gain – about $4 bln of profit for Pfizer this year – may pale beside the benefit from having regulators and lawmakers on their side.